Shareholders meeting

Nectar Lifesciences Ltd. Ref No.: NLL/CS/2026- 730 September 18, 2026 1. National Stock Exchange of India Limited 2. BSE Limited Listing Department, Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, P J Towers, Dalal Street, Bandra (E), Mumbai 400 051 Mumbai 400 001 Symbol: NECLIFE Scrip Code: 532649 Sub: Proceedings of 31st Annual General Meeting (“AGM”) of the Nectar Lifesciences Limited (“Company”). Dear Sir/Madam, Pursuant to regulation 30 of Securities and Exchange of Board of India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“LODR Regulations”) please find enclosed herewith proceedings of AGM held on Friday, September 18, 2026. This is for your information and records please. Thanking you, Yours faithfully, For Nectar Lifesciences Limited (Sanjaymohan Singh Rawat) Company Secretary & Compliance Officer Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664 Nectar Lifesciences Ltd. Summary of the proceedings at the 31st AGM of the Company The 31st AGM of the Company held on Friday, September 18, 2026 at 11:00 A.M. Indian standard time (“IST”) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) in compliance with General Circular Nos. 14/2020 dated April 8, 2020, 17/2020 dated April 13, 2020, 20/2020 dated May 05, 2020 read with other relevant circulars issued in this regard, the latest being General Circular No. 03/ 2025 dated September 22, 2025 (collectively referred to as “MCA Circulars”) and SEBI vide its Circular dated May 12, 2020, January 15, 2021, May 13, 2022, January 5, 2023, October 07, 2023 and October 3, 2024. Following Directors were present: 1. Mr. Sanjiv Goyal- Chairman & Managing Director; 2. Dr. Indu Pal Kaur- Independent Director; 3. Dr. Kuldeep Kumar Bhasin- Independent Director and Chairperson of Stakeholders Relationship Committee; 4. Dr. Rupinder Tewari- Independent Director and Chairperson of Audit Committee and Nomination & Remuneration Committee; 5. Mr. Sushil Kapoor- Whole-time Director & Chief Financial Officer; and 6. Dr. Gunmala Suri- Additional Non-Executive Non-Independent Director In Attendance: 1. Mr. Deepak Jindal- Partner of M/s. Deepak Jindal & Co., Chartered Accountants, Statutory Auditors; 2. Mr. Prince Chadha- Proprietor of P. Chadha & Associates., Company Secretaries, Secretarial Auditors; and 3. Mr. Sanjaymohan Singh Rawat- Company Secretary & Compliance Officer Company Secretary welcomed the Shareholders, Directors and others at the 31st AGM. Mr. Sanjiv Goyal, Chairman & Managing Director, chaired the AGM. The Chairman informed that the Company had made all efforts feasible under the circumstances to enable the members to participate at the meeting through the VC and vote electronically. The quorum being present Chairman declared the meeting open. Thereafter, the Chairman addressed the Shareholders. Company Secretary briefed the shareholders about certain important points regarding the Meeting. The Statutory Auditors, M/s. Deepak Jindal & Co., Chartered Accountants and Secretarial Auditors, P. Chadha & Associates, has expressed unqualified opinion in the respective audit reports for the financial year 2025- 2026. There were no qualifications, observations or adverse comments on financial statements and matters, which have any material bearing on the functioning of the Company. Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664 Nectar Lifesciences Ltd. Thereafter, he has informed the members that the Company has appointed KFin Technologies Limited (“KFin”), the Registrar & Share Transfer Agent (“RTA”) of the Company as the service provider for providing the facility of electronic voting (Remote e-voting) to members of the Company from Tuesday, September 15, 2026, at 9:00 A.M. to Thursday, September 17, 2026, at 5:00 P.M. (Remote e-voting period) AND E-Voting conducted at the AGM (“Insta Poll”) At the AGM, the Chairman of the Company had called for Insta Poll i.e. an e-voting to facilitate the members present at the meeting who could not participate in the Remote e-voting to record their votes through the e-voting process through the facility as provided by KFin. Members, whose names appeared in the Register of Members / list of Beneficial Owners on the close of the day on Friday, September 12, 2026 (“Cut-off date”), i.e. the date prior to the commencement of book closure, were entitled to vote on the Resolutions set forth in the Notice of 31st AGM through Remote e-voting and Insta Poll. He added that Mr. Prince Chadha proprietor of P. Chadha & Associates, Practicing Company Secretary as the Scrutinizer to scrutinize the remote E-Voting and E-Voting at the AGM in a fair and transparent manner and the voting results will be notified to Stock Exchanges within two (2) working days of the conclusion of the meeting, in the format prescribed under Regulation 44(3) of LODR Regulations, and the same will be uploaded on Company’s and e-voting agency (Kfin) websites. With the permission of Chairman, the following business was transacted: Sr. Proposer Ordinary/ Resolution Description No. (Management/ Special Shareholder) ORDINARY BUSINESS 1. Management Ordinary To receive, consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2026, and the Reports of the Board of Directors and Auditors thereon and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Report of Auditors thereon. 2. Management Ordinary To appoint a director in place of Mr. Sanjiv Goyal (DIN- 00002841), who retires by rotation and being eligible, offers himself for re-appointment. SPECIAL BUSINESS 3. Management Special To consider and approve the re-appointment of Dr. Kuldip Kumar Bhasin (DIN- 09250008) as an Independent Director for the second term of consecutive five years. 4. Management Special To consider and approve the re-appointment of Dr. Indu Pal Kaur (DIN- 09686862) as an Independent Director for the second term of consecutive five years. Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664 Nectar Lifesciences Ltd. 5. Management Ordinary To consider and approve the appointment of Dr. Gunmala Suri (DIN- 11879344) as a Non-Executive Non-Independent Director of the Company. In conclusion of AGM, Chairman on behalf of the Board of Directors of the Company appreciated the total commitment, dedication and hard work, put in by every member of Nectar Lifesciences Limited and thanked all the members for their trust and believe in the Company. The Chairman then thanked the members present and declared the meeting closed at 11: 25 A.M. IST (including time allowed for Insta Poll). Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664